Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584–90.

Article  PubMed  PubMed Central  Google Scholar 

Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology. 2015;149:1700–15.

Article  PubMed  Google Scholar 

He Y, Liang D, Du L, Guo T, Liu Y, Sun X, et al. Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China. Cancer Commun. 2020;40:531–44.

Article  Google Scholar 

Watanabe M, Toh Y, Ishihara R, Kono K, Matsubara H, Miyazaki T, et al. Comprehensive registry of esophageal cancer in Japan, 2015. Esophagus. 2023;20:1–28.

Article  PubMed  Google Scholar 

Raja S, Rice TW, Goldblum JR, Rybicki LA, Murthy SC, Mason DP, et al. Esophageal submucosa: the watershed for esophageal cancer. J Thorac Cardiovasc Surg. 2011;142:1403–11.e1401.

Article  PubMed  Google Scholar 

Zhang X, Ma L, Xue M, Sun Y, Wang Z. Advances in lymphatic metastasis of non-small cell lung cancer. Cell Commun Signal. 2024;22:201.

Article  PubMed  PubMed Central  Google Scholar 

Nakamura Y, Yasuoka H, Tsujimoto M, Kurozumi K, Nakahara M, Nakao K, et al. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer. J Clin Pathol. 2006;59:77–82.

Article  PubMed  PubMed Central  Google Scholar 

Hsu WH, Hsu PK, Hsieh CC, Huang CS, Wu YC. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg. 2009;13:1913–20.

Article  PubMed  Google Scholar 

Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014;14:159–72.

Article  PubMed  Google Scholar 

Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Reviews Cancer. 2002;2:573–83.

Article  PubMed  Google Scholar 

Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol. 2017;12:36–42.

Article  PubMed  Google Scholar 

Alessandrini F, Pezzè L, Ciribilli Y. LAMPs: shedding light on cancer biology. Semin Oncol. 2017;44:239–53.

Article  PubMed  Google Scholar 

Agarwal AK, Gude RP, Kalraiya RD. Regulation of melanoma metastasis to lungs by cell surface Lysosome Associated Membrane Protein-1 (LAMP1) via galectin-3. Biochem Biophys Res Commun. 2014;449:332–7.

Article  PubMed  Google Scholar 

Saitoh O, Wang WC, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 1992;267:5700–11.

Article  PubMed  Google Scholar 

Agarwal AK, Srinivasan N, Godbole R, More SK, Budnar S, Gude RP, et al. Role of tumor cell surface lysosome-associated membrane protein-1 (LAMP1) and its associated carbohydrates in lung metastasis. J Cancer Res Clin Oncol. 2015;141:1563–74.

Article  PubMed  PubMed Central  Google Scholar 

Marzinke MA, Choi CH, Chen L, Shih IeM, Chan DW, Zhang H. Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery. Mol Cell Proteomics. 2013;12:356–68.

Article  PubMed  PubMed Central  Google Scholar 

Liao L, He Y, Li SJ, Yu XM, Liu ZC, Liang YY, et al. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 2023;33:355–71.

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zheng Y, Faheem A, Sun T, Li C, Li Z, et al. A novel AKT inhibitor, AZD5363, inhibits phosphorylation of AKT downstream molecules, and activates phosphorylation of mTOR and SMG-1 dependent on the liver cancer cell type. Oncol Lett. 2016;11:1685–92.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Xu X, Wang T, Guo Q, Dai X, Guo H, et al. Ceritinib increases sensitivity of AKT inhibitors to gastric cancer. Eur J Pharmacol. 2021;896:173879.

Article  PubMed  Google Scholar 

Hirai H, Sootome H, Nakatsuru Y, Miyama K, Taguchi S, Tsujioka K, et al. MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo. Mol Cancer Ther. 2010;9:1956–67.

Article  PubMed  Google Scholar 

Leng X, He W, Yang H, Chen Y, Zhu C, Fang W, et al. Prognostic impact of postoperative lymph node metastases after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of esophagus: from the results of NEOCRTEC5010, a Randomized Multicenter Study. Ann Surg. 2021;274:e1022–e1029.

Article  PubMed  Google Scholar 

Kashima H, Noma K, Ohara T, Kato T, Katsura Y, Komoto S, et al. Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma. Int J Cancer. 2019;144:828–40.

Article  PubMed  Google Scholar 

Wang Y, Zhang W, Liu W, Huang L, Wang Y, Li D, et al. Long noncoding RNA VESTAR regulates lymphangiogenesis and lymph node metastasis of esophageal squamous cell carcinoma by enhancing VEGFC mRNA stability. Cancer Res. 2021;81:3187–99.

Article  PubMed  Google Scholar 

Yun JK, Kim HR, Park SI, Kim YH. Risk prediction of occult lymph node metastasis in patients with clinical T1 through T2 N0 esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2022;164:265–75.e265.

Article  PubMed  Google Scholar 

Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem. 1991;266:21327–30.

Article  PubMed  Google Scholar 

Schwake M, Schröder B, Saftig P. Lysosomal membrane proteins and their central role in physiology. Traffic. 2013;14:739–48.

Article  PubMed  Google Scholar 

Yogalingam G, Bonten EJ, van de Vlekkert D, Hu H, Moshiach S, Connell SA, et al. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell. 2008;15:74–86.

Article  PubMed  PubMed Central  Google Scholar 

Singhal A, Szente L, Hildreth JEK, Song B. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1. Cell Death Dis. 2018;9:1019.

Article  PubMed  PubMed Central  Google Scholar 

Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, et al. Sensitive and viable identification of antigen-specific CD8 + T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281:65–78.

Article  PubMed  Google Scholar 

Krzewski K, Gil-Krzewska A, Nguyen V, Peruzzi G, Coligan JE. LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood. 2013;121:4672–83.

Article  PubMed  PubMed Central  Google Scholar 

Krishnan V, Bane SM, Kawle PD, Naresh KN, Kalraiya RD. Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis. 2005;22:11–24.

Article  PubMed  Google Scholar 

Huang J, Li L, Liu J, Yu J, Wu X, Xu Y, et al. Altered expression of lysosomal associated membrane protein 1 in esophageal squamous cell carcinoma. Pathol Res Pract. 2017;213:938–42.

Article  PubMed  Google Scholar 

Li L, Xu Y, Wang W, Zhang G, Ma M, Huang J. LAMP1 is more sensitive than LAMP2 in predicting prognosis of esophageal squamous cell carcinoma. Transl Cancer Res. 2020;9:2243–8.